KATHLEEN SCHWEGLER: Open Payments
NPI 1912308479 · FEDERAL WAY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 64 payments from 18 companies in 2025. Trend: 2023 $1,234 · 2024 $2,146 · 2025 $1,351
Food & beverage: $1,351
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $339 |
| Ardelyx, Inc. | 10 | $231 |
| Janssen Biotech, Inc. | 7 | $172 |
| Madrigal Pharmaceuticals | 5 | $116 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| PFIZER INC. | 3 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $69 |
| SHIELD THERAPEUTICS INC | 2 | $41 |
| Lilly USA, LLC | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
Products named: IBSRELA, TREMFYA, RINVOQ, REZDIFFRA, CREON, DUPIXENT, LINZESS, ENTYVIO.
Industry payments across WA — which companies pay providers there.
